Publication | Closed Access

Oral administration of type-II collagen peptide 250–270 suppresses specific cellular and humoral immune response in collagen-induced arthritis

ImmunologyImmune RegulationOral AdministrationInnate ImmunityImmune SystemType-ii CollagenInflammatory ArthritisInflammationOsteoarthritisInflammatory Rheumatic DiseaseRheumatologyAllergyAutoimmune DiseaseChronic InflammationHumoral ImmunityImmune-mediated Inflammatory DiseasesInflammatory DiseaseAnti-inflammatoryCollagen-induced ArthritisMedicine